Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study

JM Michot, R Bouabdallah, U Vitolo, Jeanette Doorduijn, G Salles, A Chiappella, PL Zinzani, F Bijou, MJ Kersten, R Sarmiento, S Mosulen, C Mendez, S Uttamsingh, M Pourdehnad, K Hege, TL Chen, C Klein, PR Hagner, Z Nikolova, V Ribrag

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)E649-E659
JournalLancet Haematology
Issue number9
Publication statusPublished - 2020

Cite this